- Capricor's DMD therapy lacks efficacy, FDA says ahead of adcommThe FDA is again questioning the efficacy of Capricor's cell therapy for Duchenne muscular dystrophy, this time ahead of an advisory committee meeting on Wednesday. The agency's review team said it…
- Six wellness peptides win backing from FDA advisory committeeAfter two days of meetings, an FDA advisory committee last week voted to lift restrictions on six popular health and wellness peptides, setting aside FDA staff concerns about a lack of safety and e…